-
461
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y glo...
Published 2025-02-01“…To further assess the reproducibility of clinical trial results, we reconstructed the “KN024 look-alike” cohort by excluding patients with an Eastern Cooperative Oncology Group-performance status (ECOG-PS)≥2, those requiring corticosteroids with doses ≥10 mg of prednisolone/equivalent, patients with positive/unknown epidermal growth factor receptor/anaplastic lymphoma kinase genotype, and those with pre-existing autoimmune disease. We additionally provided a hierarchical organization of determinants of long-term benefit through a conditional inference tree analysis.Results The study included 1050 patients from 61 institutions across 14 countries, with a median follow-up of 70.3 months. …”
Get full text
Article -
462
The Impact of Osteopontin Gene Variations on Multiple Sclerosis Development and Progression
Published 2012-01-01Get full text
Article -
463
-
464
Clinical and Pathological Roles of Ro/SSA Autoantibody System
Published 2012-01-01“…Although the presence of these autoantibodies is one of the criteria for the diagnosis and classification of SS, they are also sometimes seen in other systemic autoimmune diseases. In the last few decades, the knowledge of the prevalence of anti-Ro/SSA antibodies in various autoimmune diseases and symptoms has been expanded, and the clinical importance of these antibodies is increasing. …”
Get full text
Article -
465
Refractory Immunological Thrombocytopenia Purpura and Splenectomy in Pregnancy
Published 2015-01-01Get full text
Article -
466
Long-Term Provision of Acidified Drinking Water Fails to Influence Autoimmune Diabetes and Encephalomyelitis
Published 2018-01-01“…Induction of autoimmune diseases is predisposed by background genetics and influenced by environmental factors including diet and infections. …”
Get full text
Article -
467
Efferocytosis and inflammation: a bibliometric and systematic analysis
Published 2025-02-01Get full text
Article -
468
-
469
-
470
Clinical and Pathological Features of Childhood-Onset Nemaline Myopathy: A Report of Four Cases
Published 2012-01-01“…We examined whether immunological abnormalities can be found in the specimens of four childhood-onset nemaline myopathy (NM) patients without autoimmune diseases. Pathological examination revealed that nemaline rods were found in all specimens. …”
Get full text
Article -
471
A Man with Unilateral Endophthalmitis: A Case of Disseminated Nocardiosis
Published 2015-01-01Get full text
Article -
472
-
473
Th17 Cells in Autoimmune and Infectious Diseases
Published 2014-01-01“…The characteristics of Th17 cells, cytokines, and their sources, as well as their role in infectious and autoimmune diseases, are discussed in this review.…”
Get full text
Article -
474
The Missing LNK: Evolution from Cytosis to Chronic Myelomonocytic Leukemia in a Patient with Multiple Sclerosis and Germline SH2B3 Mutation
Published 2022-01-01“…It is established that there is a strong association of CMML with preceding or coexisting autoimmune diseases and systemic inflammatory syndromes affecting around 20% of patients. …”
Get full text
Article -
475
Osteopontin at the Crossroads of Inflammation and Tumor Progression
Published 2017-01-01Get full text
Article -
476
The Effects of Meditation, Breathing Exercises, and Cold Exposure using the Wim Hof Method on the Autonomic Nervous System: A Systematic Review
Published 2024-11-01“…Two other studies indicated that exercises associated with the Wim Hof Method positively influence the autonomic nervous system, suggesting potential benefits in managing autoimmune diseases. Conclusion These exercises were notably effective in reducing symptoms of autoimmune diseases. …”
Get full text
Article -
477
Adalimumab Induced or Provoked MS in Patient with Autoimmune Uveitis: A Case Report and Review of the Literature
Published 2016-01-01“…Anti-tumor necrosis factor α (anti-TNF-α) agents have been widely used in the field of autoimmune diseases and have proved decisive efficacy and relative safety. …”
Get full text
Article -
478
Combined Treatment with Zinc Aspartate and Intravenous Immunoglobulins (IVIGs) Ameliorates Experimental Autoimmune Encephalomyelitis (EAE)
Published 2018-01-01“…In addition, IVIG application is used off-label for treatment of other autoimmune diseases, e.g., multiple sclerosis (MS), an inflammatory autoimmune disorder with a clear T cell-mediated immune pathogenesis. …”
Get full text
Article -
479
Potential Application of Tregitopes as Immunomodulating Agents in Multiple Sclerosis
Published 2011-01-01“…Quantitative and qualitative defects of Tregs have been postulated to contribute to failed immune regulation in multiple sclerosis (MS) and other autoimmune diseases. This paper highlights the potential uses of T regulatory cell epitopes (Tregitopes), natural Treg epitopes found to be contained in human immunoglobulins, as immunomodulating agents in MS. …”
Get full text
Article -
480